GL1X · GenesisL1 explorer

MolNFT v1 · #64351 · protein

Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 4

3G0U: “Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 4”. X-ray diffraction, 3 ligands (ORO, FMN, MDY), 4 pockets (best druggability 0.84). MolNFT v1 #64351 on GenesisL1: 3D structure, binding sites…

PDB
3G0U
Type
protein
Length
361 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydroorotate dehydrogenase
EC
1.3.3.1
UniProt
Q02127
Ligands
ORO, FMN, MDY
Pockets
4 · best druggability 0.84

Structure

x-ray diffraction · 1 distinct chain · 47% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADihydroorotate dehydrogenase (EC 1.3.3.1)protein36147% helix, 16% strandQ02127

Ligands and binding sites

  • ORO · Orotic acid · ligand · chains A
  • FMN · Flavin mononucleotide · ligand · chains A
  • MDY · (2Z)-N-(3-chloro-2'-methoxybiphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14290.840.9260ORO, FMN, MDY
2920.420.7820empty
3890.380.7721empty
4760.320.7421empty

Compared structures

  • 3G0U · Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 4 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.